Jasper Ridge Partners’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $30.6K | Hold |
|
|||||
|
2023
Q4 | $16.5K | Sell |
|
|||||
|
2023
Q3 | $325K | Sell |
|
|||||
|
2023
Q2 | $902K | Hold |
|
|||||
|
2023
Q1 | $1.42M | Hold |
|
|||||
|
2022
Q4 | $1.75M | Buy |
|
|||||
|
2022
Q3 | $4.17M | Hold |
|
|||||
|
2022
Q2 | $4.09M | Buy |
|
|||||
|
2022
Q1 | $4.75M | Buy |
|
|||||
|
2021
Q4 | $5.5M | Hold |
|
|||||
|
2021
Q3 | $6.52M | Hold |
|
|||||
|
2021
Q2 | $6.12M | Buy |
|
|||||
|
2021
Q1 | $8.97M | Hold |
|
|||||
|
2020
Q4 | $9.35M | Hold |
|
|||||
|
2020
Q3 | $4.91M | Hold |
|
|||||
|
2020
Q2 | $6.09M | Hold |
|
|||||
|
2020
Q1 | $3.81M | Buy |
|
|||||
|
2019
Q4 | $5.68M | Sell |
|
|||||
|
2019
Q3 | $4.85M | Buy |
|
|||||
|
2019
Q2 | $5.11M | Buy |
|